OTCPK:CRTHF (China)
Â
Ordinary Shares
$
2.076
(0%)
10:09 PM EST
Business Description
CARsgen Therapeutics Holdings Ltd
ISIN : KYG1996C1006
Share Class Description:
CRTHF: Ordinary SharesTotal Employee Number:
362Compare
Compare
Traded in other countries / regions
02171.Hong KongCRTHF.USA IPO Date
2022-02-18Description
CARsgen Therapeutics Holdings Ltd is a clinical-stage biopharmaceutical company discovering, researching, and developing cell therapies in the People's Republic of China and the United States of America. During the year, a majority of the Group's revenue was derived from one customer located in the Chinese mainland.
Financial Strength
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 18.16 | |||||
Equity-to-Asset | 0.61 | |||||
Debt-to-Equity | 0.08 | |||||
Debt-to-EBITDA | -0.66 | |||||
Piotroski F-Score | 5/9 | |||||
Altman Z-Score | 0.16 | |||||
Beneish M-Score | -0.41 | |||||
WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year EBITDA Growth Rate | 56.4 | |||||
3-Year EPS without NRI Growth Rate | 52.8 | |||||
3-Year FCF Growth Rate | 32.6 | |||||
3-Year Book Growth Rate | -31.7 | |||||
Future 3-5Y Total Revenue Growth Rate Estimate | 180.27 |
Momentum Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 100 | |||||
9-Day RSI | 100 | |||||
14-Day RSI | 99.97 | |||||
12-1 Month Momentum % | 126.32 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 5.73 | |||||
Quick Ratio | 5.7 | |||||
Cash Ratio | 5.41 | |||||
Days Inventory | 66.43 | |||||
Days Sales Outstanding | 41.2 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | 0.5 | |||||
Shareholder Yield % | 2.6 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 63.65 | |||||
Operating Margin % | -181.29 | |||||
Net Margin % | -77.58 | |||||
EBITDA Margin % | -74.21 | |||||
FCF Margin % | -191.86 | |||||
OCF Margin % | -186.99 | |||||
ROE % | -10.56 | |||||
ROA % | -6.61 | |||||
ROIC % | -73.97 | |||||
3-Year ROIIC % | -201.53 | |||||
ROC (Joel Greenblatt) % | -90.31 | |||||
ROCE % | -7.63 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Forward PE Ratio | 296.57 | |||||
PS Ratio | 61.2 | |||||
PB Ratio | 9.66 | |||||
Price-to-Tangible-Book | 9.89 | |||||
EV-to-EBIT | -75.21 | |||||
EV-to-EBITDA | -77.14 | |||||
EV-to-Revenue | 57.25 | |||||
EV-to-FCF | -29.73 | |||||
| Price-to-Net-Current-Asset-Value | 11.53 | |||||
| Price-to-Net-Cash | 12.21 | |||||
Earnings Yield (Greenblatt) % | -1.33 | |||||
FCF Yield % | -3.05 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with OTCPK:CRTHF
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
CARsgen Therapeutics Holdings Ltd Executives
DetailsGF Valueâ„¢
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 17.703 | ||
| EPS (TTM) ($) | -0.025 | ||
| Beta | -0.8392 | ||
| 3-Year Sharpe Ratio | 0.27 | ||
| 3-Year Sortino Ratio | 0.69 | ||
| Volatility % | 129.22 | ||
| 14-Day RSI | 99.97 | ||
| 14-Day ATR ($) | 0.013286 | ||
| 20-Day SMA ($) | 2.0012 | ||
| 12-1 Month Momentum % | 126.32 | ||
| 52-Week Range ($) | 0.76 - 2.2 | ||
| Shares Outstanding (Mil) | 570.53 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 5 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
CARsgen Therapeutics Holdings Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
CARsgen Therapeutics Holdings Ltd Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| Second quarter earnings results for 2026 | 2026-08-14 | In 37 days | ||
| General meeting for 2026 | 2026-05-22 10:00 | 1.72 (+0.00%) | ||
| Annual report for 2025 | 2026-04-10 | 1.72 (+0.00%) | ||
| Second quarter earnings results for 2025 | 2025-08-15 | 0.76 (+0.00%) | ||
| General meeting for 2025 | 2025-05-22 10:00 | 0.76 (+0.00%) | ||
| Annual report for 2024 | 2025-04-16 | 0.76 (+0.00%) | ||
| Second quarter earnings results for 2024 | 2024-09-09 | 0.76 (+0.00%) |
Show
Entries
CARsgen Therapeutics Holdings Ltd Frequently Asked Questions
What is CARsgen Therapeutics Holdings Ltd(CRTHF)'s stock price today?
The current price of CRTHF is $2.08. The 52 week high of CRTHF is $2.20 and 52 week low is $0.76.
When is next earnings date of CARsgen Therapeutics Holdings Ltd(CRTHF)?
The next earnings date of CARsgen Therapeutics Holdings Ltd(CRTHF) is 2026-08-14 Est..
Does CARsgen Therapeutics Holdings Ltd(CRTHF) pay dividends? If so, how much?
CARsgen Therapeutics Holdings Ltd(CRTHF) does not pay dividend.
Guru Commentaries on OTCPK:CRTHF
No articles.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on CARsgen Therapeutics Holdings Ltd
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers